“If you would like to get the latest updates on HeartBeat.bio please refer to our press releases or partner news below or follow us onLinkedInor Twitter. “
Outreach activities
August 2022
Join this virtual panel discussion to identify ways to overcome common challenges in 3D biology research, regardless of where you are in your journey.
VIENNA, Austria – 5 October 2022 – HeartBeat.bio AG has entered a collaboration with Boehringer Ingelheim for the investigation of human cardiac organoids (Cardioids) for high-throughput early safety assessment and drug discovery.
VIENNA and SAN JOSE, CA – Sept. 12 – HeartBeat.bio AG, a biotech company developing cardiac organoids (Cardioids) for drug discovery, and Molecular Devices, LLC., a leading provider of high-performance life science solutions, have entered into a co-development agreement...
Vienna, Austria – 04 May 2021 – HeartBeat.bio AG, a spin-off company of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA)...
scientific publications
bioRxiv, July 2022
Multi-chamber cardioids unravel human heart development
In Laborschalen wachsen Herzkammern im Miniformat. Die Technik bildet menschliche Organe nach und kann in der Forschung den Einsatz von Tierexperimenten verringern.
